Psychopharmacology Maastricht

The psychopharmacology department at Maastricht University focuses on the cognitive, behavioral, and biological effects of various substances, ranging from pharmaceutical to recreational drugs.

Learn More
hero-decor

Maastricht Psychedelic Symposium

On May 24, the Maastricht Psychedelic Research Team organized a mini-symposium on psychedelics. We welcomed two international speakers: Prof. dos Santos and Prof. Bouso from Brazil and Spain to discuss their ayahuasca and ibogaine research. We also had several internal speakers: presenting on mystical vs. autobiographical psychedelic experiences (Dr Kangaslampi), microdosing (Ms. Haijen), and 5-MeO-DMT (Mr. Reckweg).

Click below to watch the entire symposium

Watch the Live Stream
img-2-intro
featured study

Read about our new paper on the neurological origins of a visual psychedelic hallucination

Congratulations to Zeus Tipado on his newly published paper that introduces a new theory as to why a person experiences a visual trip on psychedelics.

Read The Paper

Participate in our studies!

We're always conducting research in our department and we're frequently looking for participants to be a part of science! If you're interested, look at the studies that we are currently conducting.

View All Studies
img-2-intro

Dr. Malin Vedøy Uthaug

5-MeO-DMT, Consciousness, Ayahuasca

I am an altered states of consciousness researcher from Norway and one of the world leading experts on 5-MeO-DMT.

Prof. Arjan Blokland

Acetylcholine, Cognition, Learning & Memory

I studied Psychology at the Radboud University (Nijmegen, NL). After receiving my PhD in Maastricht in 1992, I did a post doc at the University of Cambridge in 1992.

Dr. Kim Kuypers

Microdosing, Cognition, Nutrition

My research focuses on the neurobiology of flexible cognition, empathy, and well-being.

Mauro Cavarra, MSc

Psychosomatics, Chronic Pain, Psychedelic-Assisted Psychotherapy

I am a psychotherapist, hypnotherapist and clinical trainer interested in understanding the connection between mind and body. At the Department I work in research projects that explore the potential of psychedelic therapies in the treatment...

Dr. Rudy Schreiber

CNS Drug Discovery, Research Domain Criteria

I started my career in central nervous system drug discovery in 1993 and subsequently progressed from bench scientist to senior leadership roles at global pharmaceutical companies

Henry Whitfeld, MSc

Psilocybin, Psychotherapy, Ideography

After being a psychological therapist with 20years experience in trauma work and mindfulness-informed approaches, I am now a researcher investigating how psychedelic experiences and psychotherapeutic protocols interact.

Dr. C. Rob Markus

Brain, Behavior, Stress

I became an expert on the relation between stress, brain (gene) vulnerability and the development of cognitive-affective complaints/disorders as well as in testing (claims about) dietary treatment/assessment methods.

Dr. Pim Heckman

Memory recovery, Sleep loss, Neuroplasticity

My academic training and research experience have provided me with an excellent background in multiple psychological disciplines including neurobiology, neuropsychology, and neuropsychopharmacology.

Pablo Mallaroni, MSc

Psychedelics, fMRI/MRS, Idiosyncracy

I am PhD candidate with the Psychopharmacology Unit of Maastricht University with a background in translational neuroscience.

We are always up for communicating with people that have interesting ideas or questions. If you want to contact our department, please reach out using this form below.

Copyright 2024 © Psychopharmacology Department at Maastricht University, All Rights Reserved